Sonablate Corp.

Sonablate HIFU is a pioneering brand in the field of prostate care, offering the most customizable and minimally-invasive focal treatment for ablation of diseased prostate tissue. Designed with patient safety and optimal outcomes in mind, Sonablate HIFU combines advanced technology with real-time ultrasound feedback, enabling physicians to monitor procedures with precision. This alternative to traditional treatments such as surgery or radiation has gained approval in over 50 countries and is distinguished as the first FDA-cleared focused ultrasound device for prostate tissue ablation in the U.S.

The brand is committed to enhancing disease control, supported by recent clinical data indicating favorable medium-term outcomes for patients. Sonablate HIFU integrates multiple safety features, including Tissue Change Monitoring and Reflexivity Index Monitoring, to ensure efficient and safe procedures. For urologists seeking innovative solutions, Sonablate offers tools for building successful focal therapy programs alongside resources and guidance through informative webinars. Join the forefront of prostate treatment with Sonablate HIFU's unmatched technology and expertise.